TABLE 4

Content of C16 to C20 series fatty acids in human liver microsomes, HEK293 cell lysate, and albumin preparations


[Fatty Acid]a

HEK293

HLM

BSA

HSA

HSA-FAF
16:0 6.64 51.1 4.69 58.3 9.28
16:1n-9 0.56 1.71 0.03 0.91 0.11
16:1n-7 1.29 12.8 0.38 4.67 0.38
16:2n-3 0.06 0.34 0.03 0.18 0.02
18:0 3.16 62.6 3.50 17.9 4.72
18:1n-9 7.76 67.3 3.47 46.2 3.77
18:1n-7 1.57 7.36 0.48 3.84 0.44
18:2n-9 0.02 0.52 0.03 0.37 0.03
18:2n-6 0.90 65.3 2.74 42.0 8.40
18:3n-6 0.03 1.01 0.02 0.45 0.05
18:3n-3 0.03 0.77 0.10 2.07 0.08
20:0 0.12 0.37 0.04 0.13 0.05
20:1n-11 0.04 0.11 0.00 0.09 0.00
20:1n-9 0.27 0.52 0.00 0.33 0.05
20:2n-9 0.03 0.13 0.00 0.10 0.01
20:2n-6 0.04 0.70 0.00 0.33 0.07
20:3n-9 0.11 0.62 0.00 0.13 0.04
20:3n-6 0.27 6.12 0.05 1.10 0.71
20:4n-6 1.13 32.9 0.07 5.58 2.98
20:3n-3
0.02
0.19
0.00
0.07
0.03
  • a Units for [fatty acid] are micromolar for a 1-mg/ml suspension of HLM, HEK293 cell lysate, and 2% solution (20 mg/ml) of albumin preparations.